Related Experiment Videos
Inflammation in HLA-B27-associated diseases
1Department of Bacteriology and Immunology, University of Helsinki, Finland.
Scandinavian Journal of Rheumatology. Supplement
|January 1, 1990
Summary
Infectious agents and host factors contribute to spondyloarthropathies. Persistent microbial antigens and immune responses can lead to chronic or recurrent inflammation, potentially managed by therapies targeting antigen elimination.
Area of Science:
- Immunology
- Rheumatology
- Microbiology
Background:
- Spondyloarthropathies involve complex, multifactorial pathogenetic mechanisms.
- Infective microorganisms may trigger arthritis through direct invasion, antigen persistence, or cross-reactions with host tissues or HLA-B27.
Purpose of the Study:
- To elucidate the pathogenetic mechanisms in spondyloarthropathies.
- To understand the role of microbial factors and immune responses in disease development and persistence.
Main Methods:
- Review of pathogenetic mechanisms in spondyloarthropathies.
- Analysis of the role of microbial antigens, HLA-B27, neutrophil function, and complement activation.
- Consideration of therapeutic interventions like antimicrobial therapy and sulphasalazine.
Main Results:
- Infectious triggers can lead to persistent antigens and amplified inflammatory responses.
- Hyperreactive neutrophils and enhanced complement activation, particularly in HLA-B27 positive individuals, contribute to inflammation.
- Priming of phagocytes by lipopolysaccharide may lead to recurrent inflammation upon re-exposure to antigens.
Conclusions:
- Spondyloarthropathies result from a combination of microbial triggers and exaggerated host immune responses.
- Therapies modifying antigen elimination or absorption may reduce inflammation in acute and chronic spondyloarthropathies.
- Further long-term studies are required to assess the prognostic impact of prolonged therapeutic interventions.